Your browser doesn't support javascript.
loading
Eliminating antibody polyreactivity through addition of N-linked glycosylation.
Chuang, Gwo-Yu; Zhang, Baoshan; McKee, Krisha; O'Dell, Sijy; Kwon, Young Do; Zhou, Tongqing; Blinn, Julie; Lloyd, Krissey; Parks, Robert; Von Holle, Tarra; Ko, Sung-Youl; Kong, Wing-Pui; Pegu, Amarendra; Wang, Keyun; Baruah, Kavitha; Crispin, Max; Mascola, John R; Moody, M Anthony; Haynes, Barton F; Georgiev, Ivelin S; Kwong, Peter D.
Afiliação
  • Chuang GY; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892.
  • Zhang B; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892.
  • McKee K; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892.
  • O'Dell S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892.
  • Kwon YD; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892.
  • Zhou T; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892.
  • Blinn J; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, 103020.
  • Lloyd K; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, 103020.
  • Parks R; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, 103020.
  • Von Holle T; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, 103020.
  • Ko SY; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892.
  • Kong WP; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892.
  • Pegu A; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892.
  • Wang K; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892.
  • Baruah K; Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, OX1, 3QU, United Kingdom.
  • Crispin M; Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, OX1, 3QU, United Kingdom.
  • Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892.
  • Moody MA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, 103020.
  • Haynes BF; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, 103020.
  • Georgiev IS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892.
  • Kwong PD; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892.
Protein Sci ; 24(6): 1019-30, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25800131
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Engenharia de Proteínas / Anticorpos Neutralizantes / Especificidade de Anticorpos Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Engenharia de Proteínas / Anticorpos Neutralizantes / Especificidade de Anticorpos Idioma: En Ano de publicação: 2015 Tipo de documento: Article